
MJ33 is an active-site-directed, specific, competitive, and reversible phospholipase A2 (PLA2) ингибитор. MJ33 blocks the calcium-independent phospholipase A2 (iPLA2) activity of Prdx6.
MJ33 is an active-site-directed, specific, competitive, and reversible phospholipase A2 (PLA2) inhibitor. MJ33 blocks the calcium-independent phospholipase A2 (iPLA2) activity of Prdx6.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.